The Sheikh Zayed Institute for Pediatric Surgical Innovation - Product Pipeline Analysis, 2023 Update

Summary
The Sheikh Zayed Institute for Pediatric Surgical Innovation (Sheikh Zayed Institute) is a not-for-profit organization that offers to host a pediatric device innovation symposium. The organization’s services include infrastructure for research and development and a network of product and medical device development experts, and seasoned veterans in venture capital, technology commercialization and intellectual property. It also provides clinical themes to transform pediatric surgical innovation and intervention, pediatric pain and anesthesia and systems biology. Sheikh Zayed Institute offers cardiovascular physiology services such as subcellular mechanistic studies, 3D tissue-engineered cardiac models, whole heart optical mapping, and in vivo electrophysiology services. The organization provides bioengineering, immunology and molecular biology, and pain medicine services, among others. Sheikh Zayed Institute is headquartered in Washington, WashingtonD.C., the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developmentsThe report analyzes all pipeline products in development for the company The Sheikh Zayed Institute for Pediatric Surgical InnovationThe report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch dateThe report provides detailed description of products in development, technical specification and functionsThe report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.Reasons to Buy:Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapeDesign and develop your product development, marketing and sales strategies by understanding the competitor portfolioTo formulate effective Research & Development strategiesDevelop market-entry and market expansion strategiesExploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust returnPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etcIdentify, understand and capitalize the next high-value products that your competitor would add in its portfolioNote:Some sections may be missing if data is unavailable for the company